MindMed to Participate at Upcoming Investor Conferences
01 Junho 2023 - 8:00AM
Business Wire
Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED),
(the “Company” or “MindMed”), a clinical stage biopharmaceutical
company developing novel product candidates to treat brain health
disorders, announced today that members of the Company’s management
team will participate in the following investor conferences:
- BIO International Convention
- Format: Investor Presentation
- Date and Time: Monday, June 5, 2023 at 3:30 pm EDT
- Jefferies Healthcare Conference
- Format: Investor Presentation
- Date and Time: Thursday, June 8, 2023 at 2:30 pm EDT
- Webcast Link: Jefferies Healthcare Conference
Audio webcasts and replays of available presentations will be
accessible on MindMed’s Investor Resources website for up to 90
days following each event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders.
MindMed trades on NASDAQ under the symbol MNMD and on the
Canadian NEO Exchange under the symbol MMED.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230601005256/en/
For Media & Investor Inquiries, please contact:
Maxim Jacobs, CFA Vice President, Investor Relations and
Corporate Communications Mind Medicine (MindMed) Inc. ir@mindmed.co
media@mindmed.co
Mind Medicine MindMed (NASDAQ:MNMD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Mind Medicine MindMed (NASDAQ:MNMD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024